Efficacy of procedural treatments for pediatric hidradenitis suppurativa: A systematic review
Citations Over TimeTop 11% of 2023 papers
Abstract
Hidradenitis suppurativa (HS) is a painful, inflammatory skin disease that has historically been understudied in the pediatric population. Procedural interventions, such as surgical excisions, skin grafts, and lasers, are important for comprehensive HS disease management. However, there is a lack of data on procedural treatments for HS in pediatric patients. The purpose of this study was to conduct a systematic review of the literature on the efficacy and safety of procedural treatments for HS in pediatric patients. In April 2022, MEDLINE and EMBASE databases were searched for articles on the efficacy of procedural treatments for HS in patients <18 years of age. Two independent reviewers extracted data from relevant studies. From 1974 to 2021, 23 articles with 81 patients were identified. Patients' Hurley stages included stage I (9.1%, 1/11), II (36.4%, 4/11), and III (54.5%, 6/11). The most extensively studied procedural interventions include negative pressure wound therapy (n = 30), surgical excision with skin graft/flap (n = 19), and endoscopic electrode or laser treatment (n = 11). In all, promising response rates for procedural management strategies were observed in the literature but the findings were largely based on case reports/series. Randomized controlled trials (RCTs), especially those geared toward minimally invasive procedural treatments, are needed to help guide clinicians on the most efficacious treatment modalities for pediatric patients with HS.
Related Papers
- → Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1(2018)50 cited
- → Body Image Quality of Life in Patients with Hidradenitis Suppurativa Compared with Other Dermatological Disorders(2020)31 cited
- → Case report of hidradenitis suppurativa localized to the face in an HIV patient(2021)1 cited
- → Hidradenitis Suppurativa(2017)1 cited
- → Photodynamic Therapy for Hidradenitis Suppurativa(2011)